These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 2045312)

  • 41. Important considerations in the estimation of organ doses in pelvic external-beam radiation therapy after gynecologic brachytherapy.
    Abbasi AN
    Radiology; 1999 Nov; 213(2):618-9. PubMed ID: 10551253
    [No Abstract]   [Full Text] [Related]  

  • 42. Perineal template techniques for interstitial implantation of gynecological cancers using the Paris system of dosimetry.
    Leung S
    Int J Radiat Oncol Biol Phys; 1990 Sep; 19(3):769-74. PubMed ID: 2211225
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Contribution of 3D imaging in brachytherapy: which kind of imaging for which localization?].
    Dumas I; Champoudry J; Martinetti F; Haie-Meder C; Bossi A; Lefkopoulos D
    Cancer Radiother; 2013 Apr; 17(2):93-7. PubMed ID: 23490169
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Brachytherapy in Gynecologic Cancers: Why Is It Underused?
    Han K; Viswanathan AN
    Curr Oncol Rep; 2016 Apr; 18(4):26. PubMed ID: 26940059
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Basic principles and results of brachytherapy in gynecological oncology].
    Kanaev SV; Turkevich VG; Baranov SB; Savel'eva VV
    Vopr Onkol; 2014; 60(4):422-8. PubMed ID: 25552060
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical outcomes of high-dose-rate interstitial gynecologic brachytherapy using real-time CT guidance.
    Lee LJ; Damato AL; Viswanathan AN
    Brachytherapy; 2013; 12(4):303-10. PubMed ID: 23491023
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Brachytherapy in paediatric sarcoma].
    Haie-Meder C; Martelli H; Dumas I; Mazeron R; Oberlin O
    Bull Cancer; 2011 May; 98(5):549-57. PubMed ID: 21609896
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Concept of the nominal standard dosage as applied to the intracavitary therapy of oncological gynecologic patients using 60Co and 252Cf].
    Nikishin BK; Gaponenko ED; Koval' GN; Abdullaev VD
    Med Radiol (Mosk); 1979 Dec; 24(12):53-7. PubMed ID: 514002
    [No Abstract]   [Full Text] [Related]  

  • 49. New understanding from Cf brachytherapy trials and considerations for neutron therapy of bulky gyn carcinoma for future.
    Maruyama Y; Mesina J; Yudelev M; Wierzbicki J; Deppe G; Porter AT
    Strahlenther Onkol; 1994 May; 170(5):253-63. PubMed ID: 8197547
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Gynecologic brachytherapy: digital fluoroscopy for placement verification and treatment planning.
    Kavanagh BD; Zwicker RD; Segreti EM; Lindquist LA; Fulcher AS; Hundley GM; Spindler JA; Cardinale RM
    Radiology; 2000 Jun; 215(3):900-3. PubMed ID: 10831719
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A prospective analysis of catheter complications for gynecological cancers treated with interstitial brachytherapy in the 3D era.
    Mendez LC; Lang P; Patel C; D'Souza D; Gladwish A; D'Alimonte L; Taggar A; Barnes E; Barbera L; Leung E
    Brachytherapy; 2019; 18(1):44-49. PubMed ID: 30316724
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Development and evaluation of an automatic interstitial catheter digitization tool for adaptive high-dose-rate brachytherapy.
    Dise J; Liang X; Scheuermann J; Anamalayil S; Mesina C; Lin LL; Teo BK
    Brachytherapy; 2015; 14(5):619-25. PubMed ID: 26073225
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Inverse-planned gynecologic high-dose-rate interstitial brachytherapy: clinical outcomes and dose--volume histogram analysis.
    Thibault I; Lavallée MC; Aubin S; Laflamme N; Vigneault E
    Brachytherapy; 2012; 11(3):181-91. PubMed ID: 21862418
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dose distribution for gynecological brachytherapy with dose accumulation between insertions: Feasibility study.
    Reniers B; Janssens G; Orban de Xivry J; Landry G; Verhaegen F
    Brachytherapy; 2016; 15(4):504-513. PubMed ID: 27184645
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Technical note: cone beam CT imaging for 3D image guided brachytherapy for gynecological HDR brachytherapy.
    Reniers B; Verhaegen F
    Med Phys; 2011 May; 38(5):2762-7. PubMed ID: 21776813
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Gynecologic brachytherapy--from low-dose-rate to high-tech].
    Herrmann T; Christen N; Alheit HD
    Strahlenther Onkol; 1993 Mar; 169(3):141-51. PubMed ID: 8465248
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Normal tissue dosimetric comparison between HDR prostate implant boost and conformal external beam radiotherapy boost: potential for dose escalation.
    Hsu IC; Pickett B; Shinohara K; Krieg R; Roach M; Phillips T
    Int J Radiat Oncol Biol Phys; 2000 Mar; 46(4):851-8. PubMed ID: 10705005
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Attenuation of intracavitary applicators in 192Ir-HDR brachytherapy.
    Ye SJ; Brezovich IA; Shen S; Duan J; Popple RA; Pareek PN
    Med Phys; 2004 Jul; 31(7):2097-106. PubMed ID: 15305463
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Specific integral dose: a reconsideration of the integral dose concept.
    Roth J; Hünig R; Kurtz J
    Radiother Oncol; 1986 Mar; 5(3):215-21. PubMed ID: 3085170
    [TBL] [Abstract][Full Text] [Related]  

  • 60. AAPM TG-43 formalism for brachytherapy dose calculation of a 137Cs tube source.
    Zhang P; Beddar AS; Sibata CH
    Med Phys; 2004 Apr; 31(4):755-9. PubMed ID: 15124992
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.